Calidi Biotherapeutics (CLDI) Net Income towards Common Stockholders (QoQ) (2022 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Calidi Biotherapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 62.52% |
| Sep 30, 2025 | -89.36% |
| Jun 30, 2025 | -14.62% |
| Mar 31, 2025 | -21.70% |
| Dec 31, 2024 | 18.94% |
| Sep 30, 2024 | 32.05% |
| Jun 30, 2024 | -2.95% |
| Mar 31, 2024 | 12.20% |
| Dec 31, 2023 | -306.57% |
| Sep 30, 2023 | 83.81% |
| Jun 30, 2023 | -93.45% |
| Mar 31, 2023 | 16.83% |
| Dec 31, 2022 | -45.13% |
| Sep 30, 2022 | -228.66% |
| Jun 30, 2022 | 184.59% |